참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Phosgene | HCID 6371 | — |
| 반응물 | 4-Nitroimidazole | HCID 18208 | — |
| 반응물 | Cyclopropylamine | HCID 69828 | — |
| 반응물 | 5-Nitro-1(1,2,3,4-tetrahydro-naphthalen-1-yl)-1h-imidazole | HCID 59199381 | — |
| 촉매 | Palladium | HCID 23938 | — |
| 생성물 | 1-Cyclopropyl-3-[3-(1,2,3,4-tetrahydro-naphthalen-1-yl)-3h-imidazol-4-yl]-urea | HCID 59199336 | — |
반응 단계
In the first step a modified Mitsunobu reaction employing 5-nitro-1H-imidazole (CAS #3034-38-6) can be preformed as described in Example 1. The resulting 5-nitro-1(1,2,3,4-tetrahydro-naphthalen-1-yl)-1H-imidazole, can then be reduced via the employment of palladium on carbon under a hydrogen atmosphere. The resulting amine can undergo treatment with phosgene followed by the addition of cyclopropylamine to afford 1-cyclopropyl-3-[3-(1,2,3,4-tetrahydro-naphthalen-1-yl)-3H-imidazol-4-yl]-urea; MS: (ESI) m/z 297.1 (M+H)+; 1H NMR (400 MHz, CDCl3) δ ppm 0.46-0.57 (m, 2 H), 0.68-0.77 (m, 2 H), 1.78-2.29 (m, 4 H), 2.49-2.60 (m, 1 H), 2.79-3.01 (m, 2 H), 5.17-5.31 (m, 1 H), 5.34-5.43 (m, 1 H), 6.33-6.43 (m, 1 H), 6.85 (d, J=7.6 Hz, 1 H), 7.01 (s, 1 H), 7.13 (t, J=7.5 Hz, 1 H), 7.17-7.26 (m, 3 H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08436035B2 |
|---|
| 출처 데이터셋 | uspto-grants-2013_05 |
|---|
| ORD ID | ord-2ee919f6629f41c885d0e1a98e54f52e |
|---|
| 출처 메모 | uspto-grants-2013_05 |
|---|